Neil Cashman
Net worth: 121 786 $ as of 2026-08-30
Net worth: 121 786 $ as of 2026-08-30
Neil R.
Cashman is the founder of Caprion Proteomics, Inc., founded in 2000, and ProMIS Neurosciences, Inc., founded in 2004, where Dr. Cashman holds the title of Director & Chief Scientific Officer.
Dr. Cashman currently serves as Director-ALS Clinic at Vancouver General Hospital since 2005, Director at ALS Society of British Columbia, and Director at Alberta Innovates BioSolutions.
Former positions include Director-Neuromuscular Clinic at Sunnybrook & Womens Foundation, Director-UBC ALS Centre & Professor at the University of British Columbia from 2005 to 2022, and Professor at the University of Toronto from 1998 to 2005.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-19 | 9,318 ( 0.1% ) | 121 786 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Founder | 2004-01-22 |
Vancouver General Hospital | Corporate Officer/Principal | 2005-06-30 |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Director/Board Member | - |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2022-01-01 |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2004-12-31 |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Founder | - |
Sunnybrook & Womens Foundation | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunnybrook & Womens Foundation | |
Vancouver General Hospital | |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Commercial Services |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Health Technology |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Health Technology |
Select your edition
All financial news and data tailored to specific country editions